Your search matched 2 results
Patient Advocacy Transparency Act and the Growing Call for Disclosure | Blog
As anticipated, on June 6, 2018, Senator Claire McCaskill (D-Mo.) introduced the Patient Advocacy Transparency Act.
Advancing the Patient Voice in Clinical Trials | Blog
Recently, the FDA issued Collecting Comprehensive and Representative Input, the first of four patient-focused drug development (PFDD) guidance documents.
Already have a RSS feed reader?
